Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › Seventh Sense Blood Collection Device Gets CE Mark

Seventh Sense Blood Collection Device Gets CE Mark

Mar 29, 2018
|
staff reporter

NEW YORK (360Dx) – Seventh Sense Biosystems today announced that its TAP blood collection device has received CE marking.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Regulatory News & FDA Approvals

  1. DiaSorin Receives CE Mark to Use Saliva Samples With COVID-19 Test

  2. Roche Nabs CE Mark for SARS-CoV-2 Quantitative Antibody Test

  3. FDA Grants Emergency Use Authorization to Coronavirus Tests From Visby Medical, SNIBE

  4. FDA Proposes Reclassification of Cytomegalovirus Quantitative Tests

  5. Roche Gets FDA Emergency Use Authorization for Rapid Coronavirus, Flu Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.